We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
From the Food and Drug Administration.
- Authors
Schwetz, Bernard A.; Schwetz, B A
- Abstract
Presents medical news briefs from the United States Food and Drug Administration. Development of a revised informed consent form and medication guide to strengthen protection for patients who use isotretinoin (Accutane); Approval of an indication for letrozole as a first-line treatment for post-menopausal women with hormone receptor-positive or breast cancer; Approval of mesalamine rectal suppositories; Others.
- Subjects
UNITED States; UNITED States. Food &; Drug Administration; ISOTRETINOIN; BREAST cancer treatment; SUPPOSITORIES; ANTINEOPLASTIC agents; HETEROCYCLIC compounds; ORGANIC compounds; BREAST tumors; CLINICAL trials; DERMATOLOGIC agents; INFORMATION services; NONSTEROIDAL anti-inflammatory agents; ULCERATIVE colitis; RELATIVE medical risk; MESALAMINE; THERAPEUTICS
- Publication
JAMA: Journal of the American Medical Association, 2001, Vol 285, Issue 9, p1146
- ISSN
0098-7484
- Publication type
journal article